12.07.23 Zetomipzomib (KZR-616) Demonstrates Clinically Meaningful Renal Responses in Patients with Lupus Nephritis (LN): Results from the Phase 2 MISSION Study. 25th Asia-Pacific League of Associations for Rheumatology Congress 2023.